BACKGROUND: Several immune mechanisms activate in COVID-19 pathogenesis. Usually, coronavirus infection is characterized by dysregulated host immune responses, interleukine-6 increase, hyper-activation of cytotoxic CD8 T lymphocytes. Interestingly, Vitamin D deficiency has been often associated with altered immune responses and infections. In the present study, we evaluated Vitamin D plasma levels in patients affected with different lung involvement during COVID-19 infection. METHODS: Lymphocyte phenotypes were assessed by flow cytometry. Thoracic CT scan involvement was obtained by an image analysis program. RESULTS: Vitamin D levels were deficient in (80%) of patients, insufficient in (6.5%) and normal in (13.5%). Patients with very low Vitamin D plasma levels had more elevated D-Dimer values, a more elevated B lymphocyte cell count, a reduction of CD8 + T lymphocytes with a low CD4/CD8 ratio, more compromised clinical findings (measured by LIPI and SOFA scores) and thoracic CT scan involvement. CONCLUSIONS: Vitamin D deficiency is associated with compromised inflammatory responses and higher pulmonary involvement in COVID-19 affected patients. Vitamin D assessment, during COVID-19 infection, could be a useful analysis for possible therapeutic interventions. TRIAL REGISTRATION: 'retrospectively registered'.
BACKGROUND: Several immune mechanisms activate in COVID-19 pathogenesis. Usually, coronavirus infection is characterized by dysregulated host immune responses, interleukine-6 increase, hyper-activation of cytotoxic CD8 T lymphocytes. Interestingly, Vitamin Ddeficiency has been often associated with altered immune responses and infections. In the present study, we evaluated Vitamin D plasma levels in patients affected with different lung involvement during COVID-19infection. METHODS: Lymphocyte phenotypes were assessed by flow cytometry. Thoracic CT scan involvement was obtained by an image analysis program. RESULTS:Vitamin D levels were deficient in (80%) of patients, insufficient in (6.5%) and normal in (13.5%). Patients with very low Vitamin D plasma levels had more elevated D-Dimer values, a more elevated B lymphocyte cell count, a reduction of CD8 + T lymphocytes with a low CD4/CD8 ratio, more compromised clinical findings (measured by LIPI and SOFA scores) and thoracic CT scan involvement. CONCLUSIONS:Vitamin Ddeficiency is associated with compromised inflammatory responses and higher pulmonary involvement in COVID-19 affected patients. Vitamin D assessment, during COVID-19infection, could be a useful analysis for possible therapeutic interventions. TRIAL REGISTRATION: 'retrospectively registered'.
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Ilkka Laaksi; Juha-Petri Ruohola; Pentti Tuohimaa; Anssi Auvinen; Riina Haataja; Harri Pihlajamäki; Timo Ylikomi Journal: Am J Clin Nutr Date: 2007-09 Impact factor: 7.045
Authors: Yong Zhang; Donald Y M Leung; Brittany N Richers; Yusen Liu; Linda K Remigio; David W Riches; Elena Goleva Journal: J Immunol Date: 2012-02-01 Impact factor: 5.422
Authors: Janine Hensel; Kathleen M McAndrews; Daniel J McGrail; Dara P Dowlatshahi; Valerie S LeBleu; Raghu Kalluri Journal: Sci Rep Date: 2020-10-27 Impact factor: 4.379
Authors: Mohammed Al-Jarallah; Rajesh Rajan; Raja Dashti; Ahmad Al Saber; Jiazhu Pan; Kobalava D Zhanna; Hassan Abdelnaby; Wael Aboelhassan; Farah Almutairi; Mohammed Abdullah; Naser Alotaibi; Mohammad Al Saleh; Noor Al Nasrallah; Bader Al-Bader; Haya Malhas; Maryam Ramadhan; Mahdy Hamza; Peter A Brady; Ibrahim Al-Zakwani; Moudhi Alroomi Journal: J Med Virol Date: 2021-06-20 Impact factor: 20.693
Authors: Iacopo Chiodini; Davide Gatti; Davide Soranna; Daniela Merlotti; Christian Mingiano; Angelo Fassio; Giovanni Adami; Alberto Falchetti; Cristina Eller-Vainicher; Maurizio Rossini; Luca Persani; Antonella Zambon; Luigi Gennari Journal: Front Public Health Date: 2021-12-22